Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04304105 · ClinicalTrials.gov registry record
Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study
A clinical trial, sponsored by LimFlow.
- Completed
- Registry status
- 192
- Enrollment target
NCT04304105 is a clinical trial that has completed, run by LimFlow. The registered enrollment target is 192 participants.
The verdict
NCT04304105 has completed, sponsored by LimFlow.
- COMPLETED
- Registry status
- 192 participants
- Enrollment target
Study Summary
The objective of this observational registry is to track the clinical progression of chronic limb-threatening ischemia (CLTI) and incidence of death, amputation, and revascularization attempts over a one-year period.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 192 participants |
| Start Date | 2020-02-24 |
| Est. Completion | 2022-09-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04304105
The ClinicalTrials.gov registry entry for NCT04304105 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 192 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is LimFlow, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04304105 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04304105 about?
NCT04304105 is a clinical study titled "Natural Progression of High-Risk Chronic Limb-Threatening Ischemia: The CLariTI Study". The objective of this observational registry is to track the clinical progression of chronic limb-threatening ischemia (CLTI) and incidence of death, amputation, and revascularization attempts over a one-year period.
What is the current status of trial NCT04304105?
This trial is currently completed. The enrollment target is 192 participants. The study started on 2020-02-24. Estimated completion is 2022-09-12.
Who is sponsoring clinical trial NCT04304105?
This trial is sponsored by LimFlow, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.